Document Classification

Section Type: METHODS

Text: Between February 1989 and January 1990, 75 patients with Stage III or IV squamous cell carcinoma of the head and neck were randomized to receive : (a) AHFX-S : 1. 6 Gy/fraction, twice daily (6-h interval), 5 days/week, to a total dose of 67. 2 Gy/42 fractions/6 weeks, with a 2-week rest after 38. 4 Gy ; or (b) AFX-C : 1. 8 Gy/fraction/day, 5 daily fractions/week to 54 Gy/30 fractions/6 weeks to a large field and 1. 5 Gy/fraction/day to a boost field, 6 h after large field treatment during the last 11 treatment days, to a total dose of 70. 5 Gy/41 fractions/6 weeks.